FAS and obesity disorder: The present study demonstrates that both DHA and EPA prevent the accumulation of liver lipid relative to baseline levels over eight weeks, but that DHA is more effective than EPA for reducing FAS levels, promoting smaller lipid droplets and improving insulin resistance in the fa/fa rodent model of genetic obesity, insulin resistance, and hepatic steatosis.